1,097 results match your criteria: "The National Centre of Excellence in Youth Mental Health[Affiliation]"

Convergence on CaMK4: A Key Modulator of Autism-Associated Signaling Pathways in Neurons.

Biol Psychiatry

October 2024

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Melbourne, Victoria, Australia; St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia; Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia. Electronic address:

Article Synopsis
  • The causes of autism spectrum disorder (ASD) are not fully understood, but over 1,000 rare genetic variations are linked to the condition, complicating the search for common biological targets for therapy.
  • CAMK4, a gene encoding an enzyme critical for brain development and function, has emerged as a potential risk gene for ASD, particularly in connection to certain genetic variants related to hyperkinetic movement disorders.
  • The review emphasizes that defects in the CaMK4 signaling pathway may play a significant role in ASD pathogenesis, suggesting it as a promising target for future therapeutic interventions.
View Article and Find Full Text PDF
Article Synopsis
  • Digital health interventions (DHIs) could offer low-cost, scalable improvements in care for adults with schizophrenia, with a review assessing their efficacy through randomized controlled trials (RCTs) that incorporate human support.
  • A systematic search identified 26 RCTs involving 2,481 participants, finding no significant improvements in psychosis symptoms or overall health outcomes, though there was a notable trend towards benefits in social cognition and quality of life.
  • The study concludes that while DHIs are feasible and may improve health outcomes with human support, more high-quality research is needed to explore their long-term effectiveness and integration of technology in clinical practice.
View Article and Find Full Text PDF

Prior Appendicectomy and Gut Microbiota Re-Establishment in Adults after Bowel Preparation and Colonoscopy.

Biomedicines

August 2024

The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine and Barwon Health, Deakin University, Geelong, VIC 3220, Australia.

Emerging evidence suggests that the human vermiform appendix is not a vestigial organ but rather an immunological organ of biological relevance. It is hypothesised that the appendix acts as a bacterial 'safe house' for commensal gut bacteria and facilitates re-inoculation of the colon after disruption through the release of biofilms. To date, no studies have attempted to explore this potential mechanistic function of the appendix.

View Article and Find Full Text PDF

Sub-optimal response in schizophrenia is frequent, warranting augmentation strategies over treatment-as-usual (TAU). We assessed nutraceuticals/phytoceutical augmentation strategies via network meta-analysis. Randomized controlled trials in schizophrenia/schizoaffective disorder were identified via the following databases: PubMed, MEDLINE, EMBASE, Scopus, PsycINFO, CENTRAL, and ClinicalTrials.

View Article and Find Full Text PDF

Osteoarthritis is a leading cause of chronic pain and is associated with high rates of depression. Physical activity reduces depression symptoms and pain levels. It remains unknown if physical activity is associated with lower symptoms of depression irrespective of pain levels in individuals with osteoarthritis.

View Article and Find Full Text PDF

Background: Chronic low-grade inflammation is observed across mental disorders and is associated with difficult-to-treat-symptoms of anhedonia and functional brain changes, reflecting a potential transdiagnostic dimension. Previous investigations have focused on distinct illness categories in people with enduring illness, but few have explored inflammatory changes. We sought to identify an inflammatory signal and the associated brain function underlying anhedonia among young people with recent-onset psychosis and recent-onset depression.

View Article and Find Full Text PDF

Schizophrenia is associated with increased risk of medical comorbidity, possibly including osteoporosis, which is a public health concern due to its significant social and health consequences. In this systematic review and meta-analysis, we aimed to determine whether schizophrenia is associated with bone fragility. The protocol for this review has been registered with PROSPERO (CRD42020171959).

View Article and Find Full Text PDF

Background: Most people with mental health problems do not seek help, with delays of even decades in seeking professional help. Lack of engagement with professional mental health services can lead to poor outcomes and functional impairment. However, few effective interventions have been identified to improve help-seeking in adults, and those that exist are not widely implemented to deliver public health impact.

View Article and Find Full Text PDF

Background: Psychological interventions are a promising area for fatigue management in patients with inflammatory bowel disease (IBD). However, most interventions trialled to date have been pilots with limited direct input from patients about the type of intervention they want. Thus, this study aimed to explore patient preferences for a psychological IBD fatigue intervention.

View Article and Find Full Text PDF

Current Pharmacotherapies for Smoking Cessation and Promising Emerging Drugs.

Curr Rev Clin Exp Pharmacol

February 2024

IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, P.O. Box 281, Geelong, 3220, Australia.

Article Synopsis
  • Pharmacotherapy is used to help individuals quit smoking, but many still relapse after quit attempts, highlighting the need for effective treatments.
  • Current and emerging pharmacotherapies include new formulations and methods, but none have yet shown significantly better success rates than traditional treatments, and vaping has become a controversial alternative.
  • Successful smoking cessation often requires tailored approaches that go beyond medication, incorporating individual psychological and social factors.
View Article and Find Full Text PDF

Predictors of Functional Impairment in Bipolar Disorder: Results From 13 Cohorts From Seven Countries by the Global Bipolar Cohort Collaborative.

Focus (Am Psychiatr Publ)

October 2023

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA (Burdick, Millett, Potter, Shanahan); University of Michigan, Ann Arbor, Michigan, USA (Yocum, Diaz-Byrd, McInnis); The Milken Institute, Washington, District of Columbia, USA (Altimus, Pham); NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway (Andreassen, Lagerberg, Ueland); KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway (Andreassen); Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, Monaco (Aubin); Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France (Belzeaux); Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia (Berk, Stuart, Williams, Wrobel); Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia (Berk, Wrobel); Mayo Clinic Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA (Biernacka, Frye); Mayo Clinic Department of Quantitative Health Sciences, Mayo Clinic, Rocester, MN, USA (Biernacka); Yale School of Medicine, New Haven, Connecticut, USA (Blumberg); Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK (Cleare, Strawbridge, Young); Université de Paris, INSERM UMR1266, AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France (Dubertret); Université de Paris, AP-HP, Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS, Paris, France (Etain); University of California San Diego, La Jolla, CA, USA; Desert-Pacific Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, San Diego, California, USA (Eyler, Klaus); Division of Geriatric Psychiatry, McLean Hospital, Belmont, MA, USA (Forester); Harvard Medical School, Boston, Massachusetts, USA (Forester); Neuroscience Research Australia, Sydney, Australia (Fullerton); School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia (Fullerton); Pôle de Psychiatrie Générale et Universitaire, Centre Hospitalier Charles Perrens, Bordeaux, France (Gard); Univ Paris Est Créteil, INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Créteil, France; APHP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de Psychiatrie et d'Addictologie, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France (Godin, Leboyer); Clinical Psychiatry Department, Treatment-Resistant Depression Fondamental Expert Center, EA 481 Neurosciences, Bourgogne Franche Comté University, Besançon, France (Haffen); Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain (Martinez-Aran, Sole, Vieta); SLM Lindner Center of HOPE, Mason, Ohio, USA; University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (McElroy); School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia (Mitchell); Department of Emergency Psychiatry and Acute Care, CHU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France (Olie); Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA (Olorunfemi, Peters, Nierenberg); Service Hospitalo-Universitaire de psychiatrie d'adulte et d'addictologie, Centre Hospitalier de Versailles, INSERM UMR1018, DisAP-DevPsy-CESP, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Gif-sur-Yvette, France (Passerieux); Univ. Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences Inserm U 1216, Grenoble, France (Polosan); University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA (Sajatovic); CHU Clermont-Ferrand, Department of Psychiatry, University of Clermont Auvergne, UMR 6602 Institut Pascal, Clermont-Ferrand, France (Samalin); Université de Lorraine, Inserm U 1114, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie CPN, Laxou, France (Schwan); Department of Psychiatry, University of British Columbia, Vancouver, Canada (Torres, Yatham); Department of Psychology, University of Oslo, Oslo, Norway (Ueland); Barwon Health, Geelong, Victoria, Australia (Williams).

Objectives: Persistent functional impairment is common in bipolar disorder (BD) and is influenced by a number of demographic, clinical, and cognitive features. The goal of this project was to estimate and compare the influence of key factors on community function in multiple cohorts of well-characterized samples of individuals with BD.

Methods: Thirteen cohorts from 7 countries included = 5882 individuals with BD across multiple sites.

View Article and Find Full Text PDF

Objective: Many psychiatric disorders are linked to low grade systemic inflammation as measured by systemic cytokine levels. Exploration of cytokines and immune activity and their role in psychiatric symptoms may inform pathobiology and treatment opportunities. The aim of this study is to explore if there are associations between cytokines and psychiatric symptom clusters.

View Article and Find Full Text PDF

The coming years are likely to be turbulent due to a myriad of factors or polycrisis, including an escalation in climate extremes, emerging public health threats, weak productivity, increases in global economic instability and further weakening in the integrity of global democracy. These formidable challenges are not exogenous to the economy but are in some cases generated by the system itself. They can be overcome, but only with far-reaching changes to global economics.

View Article and Find Full Text PDF

Priorities for research promoting mental health in the south and east of Asia.

Lancet Reg Health Southeast Asia

April 2024

Association for the Improvement of Mental Health Programmes (AMH), Geneva, Switzerland.

Progress in promoting mental health, preventing mental illness, and improving care for people affected by mental illness is unlikely to occur if efforts remain separated from existing public health programs and the principles of public health action. Experts met recently to discuss integrating public health and mental health strategies in the south and east of Asia, especially in low- and middle-income countries. Areas of research identified as high priority were: 1) integrating mental health into perinatal care; 2) providing culturally-adjusted support for carers of people with mental and physical disorders; 3) using digital health technologies for mental health care in areas with limited resources and 4) building local research capacity.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has brought significant mental health challenges, particularly for vulnerable populations, including non-binary gender individuals. The COMET international study aimed to investigate specific risk factors for clinical depression or distress during the pandemic, also in these special populations.

Methods: Chi-square tests were used for initial screening to select only those variables which would show an initial significance.

View Article and Find Full Text PDF

Network-based drug repurposing for schizophrenia.

Neuropsychopharmacology

May 2024

Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.

Despite recent progress, the challenges in drug discovery for schizophrenia persist. However, computational drug repurposing has gained popularity as it leverages the wealth of expanding biomedical databases. Network analyses provide a comprehensive understanding of transcription factor (TF) regulatory effects through gene regulatory networks, which capture the interactions between TFs and target genes by integrating various lines of evidence.

View Article and Find Full Text PDF

Symptoms of depression and risk of emergency department visits among people aged 70 years and over.

BMC Public Health

February 2024

School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Background: Older people experiencing depression and anxiety have higher rates of health service utilisation than others, but little is known about whether these influence their seeking of emergency care. The aim was to examine the associations between symptoms of depression and the use of emergency health care, in an Australian context, among a population of people aged 70 years and over initially free of cardiovascular disease, dementia or major physical disability.

Methods: We undertook secondary analyses of data from a large cohort of community-dwelling Australians aged [Formula: see text]70 years.

View Article and Find Full Text PDF

Background: The prevalence of medical illnesses is high among patients with psychiatric disorders. The current study aimed to investigate multi-comorbidity in patients with psychiatric disorders in comparison to the general population. Secondary aims were to investigate factors associated with metabolic syndrome and treatment appropriateness of mental disorders.

View Article and Find Full Text PDF

Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment.

Clin Psychopharmacol Neurosci

February 2024

Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, VIC, Australia.

Article Synopsis
  • - The study aimed to investigate factors related to illness in patients with major depressive disorder (MDD) who were treated with minocycline (200 mg/day) during a 12-week clinical trial.
  • - Researchers conducted a sub-analysis of 71 participants, examining how variables like illness chronicity, systemic illnesses, and side effects influenced treatment outcomes using statistical methods.
  • - While there was a consistent trend suggesting that minocycline might benefit patients with less chronic illness and fewer side effects, these results were not statistically significant, highlighting the need for further research to identify who may respond better to anti-inflammatory treatments.
View Article and Find Full Text PDF
Article Synopsis
  • - Psychosis risk prediction in psychiatry is challenging, and a study aimed to evaluate whether a specific proteomic model could accurately predict the transition to psychosis in individuals at clinical high risk, using plasma samples from three cohorts totaling 754 participants.
  • - The study found that only 20.4% of participants developed psychosis over about 4.4 years, and the prediction model had poor accuracy (C-statistic: 0.51), suggesting that the proteomic factors didn't reliably predict outcomes.
  • - Some proteins, like Complement C8B and LRG1, showed weak associations with psychosis transition but did not reach significant levels when correcting for multiple comparisons, indicating that previous claims based on small sample sizes should
View Article and Find Full Text PDF